Oramed Pharmaceuticals Inc.
ORMP
$2.73
-$0.02-0.73%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 48.40M | 13.29M | -7.64M | -10.19M | -19.62M |
| Total Depreciation and Amortization | 31.00K | 30.00K | 30.00K | 31.00K | 52.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -59.63M | -14.21M | 5.67M | 8.23M | 10.84M |
| Change in Net Operating Assets | 9.58M | -2.64M | -1.57M | 15.00K | 1.63M |
| Cash from Operations | -1.63M | -3.54M | -3.52M | -1.91M | -7.10M |
| Capital Expenditure | 0.00 | -4.00K | -3.00K | -11.00K | -5.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 38.36M | -54.85M | 23.62M | 15.44M | -34.26M |
| Cash from Investing | 38.36M | -54.85M | 23.62M | 15.42M | -34.26M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | 0.00 | 0.00 |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -361.00K | -371.00K | -- | -1.20M | -1.29M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -361.00K | -371.00K | -- | -1.20M | -1.29M |
| Foreign Exchange rate Adjustments | 4.00K | 40.00K | -1.00K | -2.00K | 3.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 36.38M | -58.72M | 20.10M | 12.32M | -42.65M |